BD · 1 day ago
Landed Cost Optimization Manager
BD is one of the largest global medical technology companies in the world. The Landed Cost Optimization Manager is responsible for end-to-end ownership of landed cost drivers across the supply chain, partnering with various departments to manage trade risk and optimize logistics decisions to minimize costs and deliver measurable P&L impact.
Health CareMedical DeviceTechnical Support
Responsibilities
Own and govern total landed cost models across materials, components, and finished goods
Ensure accurate visibility of all landed cost elements including tariffs/duties, freight/transportation, customs brokerage and fees, insurance, surcharges, and related logistics costs
Partner with Finance to ensure landed cost accuracy in budgeting, forecasting, and actuals
Identify, quantify, and implement landed cost reduction initiatives, including tariff and duty optimization (FTAs, reclassification, exclusions, drawback), supplier and country-of-origin optimization, incoterms and logistics network optimization, mode shifting, consolidation, and freight strategy alignment
Embed landed cost considerations into sourcing, supplier selection, and make/buy decisions
Track and report realized and projected cost savings tied to procurement initiatives
Oversee tariff classification (HTS/HS), country-of-origin determinations, and customs valuation as inputs to landed cost
Ensure compliance with applicable customs and trade regulations
Liaison with customs brokers and trade service providers to ensure accuracy, cost effectiveness, and compliance
Support internal and external audits related to trade and customs activity
Monitor changes in tariff laws, free trade agreements, and life science-specific regulatory requirements
Conduct internal audits of import/export documentation and tariff classifications
Develop corrective action plans for compliance gaps and implement preventive measures
Act as the subject matter expert for total landed cost across Procurement, Supply Chain, Logistics, and Finance
Provide landed cost impact assessments for R&D, New Product Introductions (NPI), supplier transitions, dual sourcing strategies, and network or footprint changes
Influence stakeholders by translating complex cost drivers into clear business and margin impact
Develop dashboards and KPIs for landed cost drivers, savings, and risk exposure
Monitor trends and proactively identify cost pressures and mitigation opportunities
Establish SOPs, controls, and governance processes related to landed cost management
Qualification
Required
Bachelor's degree in Supply Chain, Business, Finance, International Trade, or related field
7+ years of experience in procurement, global trade, logistics, or landed cost management within manufacturing or life sciences industry
Strong knowledge of tariffs, duties, trade compliance fundamentals, freight and logistics cost structures, landed cost modeling and cost-to-serve analysis, HTS classification, customs valuation, and trade agreements
Previous experience utilizing ERP systems such as SAP particularly for documenting and reporting item and supplier level data such as country of origin relevant to landed cost
Proven track record of delivering quantifiable cost savings across multiple cost levers
Preferred
Certifications (e.g., Licensed Customs Broker, CCS, CES, CPIM, CSCP)
Benefits
Valuable, competitive package of compensation and benefits programs
Rewards and recognition opportunities that promote a performance-based culture
Company
BD
BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.
H1B Sponsorship
BD has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (66)
2022 (4)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$540MKey Investors
Steris
2023-08-02Post Ipo Equity· $540M
1962-04-23IPO
Leadership Team
Recent News
Medical Device Network
2026-01-17
2026-01-16
Med-Tech Insights
2026-01-16
Company data provided by crunchbase